Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New cPLA2 inhibitor from Merckle

Oct. 18, 1996

University of North Carolina/Macronex research cytokine inhibitors

Oct. 18, 1996

Important milestone for Connective Therapeutics' ConXn

Oct. 11, 1996

Federal research grant for novel genetic approach to arthritis

Oct. 11, 1996

Celecoxib development status in Japan

Oct. 11, 1996

Searle continues to investigate COX-2 inhibitors for inflammation

Oct. 11, 1996

Pfizer halts U.S. development of tenidap for rheumatoid arthritis

Oct. 4, 1996

Enzyme inhibitor for autoimmune diseases isolated by Japanese researchers

Oct. 4, 1996

Mercian investigators report new antiarthritic compounds

Oct. 4, 1996

Merck Frosst discloses a new series of COX-2 inhibitors

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026